1. To measure the level of expression of MXRA5 and ANXA4 genes in preeclampsia (PE). 2. To detect the effect of heavy metals (lead (Pb) and arsenic (AR)) on these two genes in the pathology of PE. 3. To explore the association of the previous two genes with the heavy metals in link with Phosphoinositide 3-kinases/Protein Kinase B (PI3K/AKT) pathway. 4. To detect Syndecan-1 by immunohistochemical antibodies. 5. To define the role of extracellular matrix remodelling in PE.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Gene expression level of MXRA5 gene in PE patients and control group
Timeframe: 1 year
Shimaa A Abd Elrahman, assistant lecturer